Guardian Research Network® and ThinkGenetic Announce Collaborative Partnership to Accelerate Diagnosis and Treatment Options for Patients with Genetic Diseases and Inherited Predisposition to Cancer Joint effort recognizes combined missions to support… CONTINUE
ThinkGenetic Selected as a Venture Atlanta 2021 Showcase Company
Over $6.5 billion in funding awarded to date; leading tech investment conference continues to select large and diverse lineup of innovators from the Southeast’s hottest tech markets ATLANTA… CONTINUE
Horizon Therapeutics Announces ThinkGenetic Curated Algorithms as Winning Solution of First-Ever Horizon Prize, Powered by MIT Solve, to Accelerate Rare Disease Diagnosis
PRESS RELEASE – Source: Horizon Therapeutics plc Horizon Therapeutics plc Announces New Genetic Counselor Curated Algorithms and Next-Generation Sequencing Data as Winning Solutions of First-Ever Horizon Prize, Powered by MIT… CONTINUE
Ochsner Lafayette Healthcare Innovation Fund Invests in ThinkGenetic Vision for Genetic Disease Identification in Local Patients
LAFAYETTE, La., April 20, 2021 (Newswire.com) – Today ThinkGenetic, Inc. (thinkgenetic.com) announces the official acceptance of a $500,000 investment from the Ochsner Lafayette General Healthcare Innovation Fund. “After years of working… CONTINUE
ThinkGenetic Announces Integration of Innovative Diagnostic Aid in Takeda Pilot Awareness Initiative
Pilot program brings genetic tools and education to patients searching for answers tied to their chronic medical conditions in Taiwan, Mexico, Argentina, Brazil, Turkey, and Russia BOSTON, December 15, 2020… CONTINUE
Ruth O’Keefe Promoted to ThinkGenetic Vice President, Marketing and Patient Advocacy
BOSTON, Ma., April 2, 2019 (Newswire.com) – ThinkGenetic, Inc. (www.ThinkGenetic.com), is excited to announce the promotion of Ruth O’Keefe to Vice President, Marketing and Patient Advocacy. ThinkGenetic, the creators of… CONTINUE
Big News for ThinkGenetic Supporters – Angel Funding Round is Closed
In a very exciting announcement from the news desk, ThinkGenetic announced the closure of its $1.5M Angel Funding round. (See the full announcement here.) When asked about the incredible accomplishment,… CONTINUE
ThinkGenetic Integrates with FDNA’s Face2Gene to Help Undiagnosed Patients Find Answers
In a public press release today, ThinkGenetic announced a collaboration with FDNA to help patients with undiagnosed genetic diseases. FDNA uses AI to detect physiological patterns that reveal genes affecting… CONTINUE